INS and type 1 diabetes mellitus: At the end of experiment, in total, inhibition of Notch signaling altered the pathophysiology of T1D in the humanized mouse model by improving serum insulin secretion (P < 0.06) as compared to the control IgG-treated group (Figure 4G).